1,173 companies

Smith Micro Software

Market Cap: US$13.0m

Engages in the development and sale of software to enhance the mobile experience to wireless and cable service providers in the Americas, Europe, the Middle East, and Africa.

SMSI

US$0.78

7D

-7.7%

1Y

-72.7%

Aldeyra Therapeutics

Market Cap: US$343.3m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ALDX

US$5.48

7D

-18.0%

1Y

54.2%

Vanda Pharmaceuticals

Market Cap: US$267.7m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$4.50

7D

-6.4%

1Y

15.1%

Redcentric

Market Cap: UK£197.4m

Provides IT managed services for public and private sector in the United Kingdom.

RCN

UK£1.24

7D

0.2%

1Y

1.0%

SideChannel

Market Cap: US$9.1m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

SDCH

US$0.04

7D

1.3%

1Y

-46.5%

DigitalOcean Holdings

Market Cap: US$3.1b

Through its subsidiaries, operates a cloud computing platform in North America, Europe, Asia, and internationally.

DOCN

US$33.79

7D

-11.0%

1Y

-9.2%

Spindox

Market Cap: €52.9m

Provides information and communication technology services in Italy and internationally.

SPN

€9.30

7D

0.6%

1Y

5.9%

Waystream Holding

Market Cap: SEK 175.5m

Provides routers and switches that are used in the fiber markets and peripherals in Sweden.

WAYS

SEK 21.75

7D

-10.5%

1Y

-9.6%

Abeona Therapeutics

Market Cap: US$231.0m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$4.45

7D

-11.0%

1Y

-40.5%

Audioboom Group

Market Cap: UK£69.5m

A podcast company, operates a spoken-word audio platform for hosting, distributing, and monetizing content primarily in the United Kingdom and the United States.

BOOM

UK£4.24

7D

-12.0%

1Y

63.1%

Ströer SE KGaA

Market Cap: €3.0b

Provides out-of-home (OOH) media and online advertising solutions in Germany and internationally.

SAX

€54.05

7D

-6.0%

1Y

-3.1%

Cogelec

Market Cap: €167.0m

Designs, manufactures, and sells access control and wireless intercom systems in France and internationally.

ALLEC

€20.00

7D

-2.0%

1Y

150.0%

Exelixis

Market Cap: US$10.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$36.39

7D

-3.5%

1Y

55.9%

Tenaya Therapeutics

Market Cap: US$92.7m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

TNYA

US$0.54

7D

-16.8%

1Y

-88.1%

KebNi

Market Cap: SEK 404.0m

Develops, manufactures, markets, and sells 4-axes stabilizing VSAT antennas for maritime applications under the KebNi Maritime brand.

KEBNI B

SEK 1.49

7D

0.7%

1Y

4.2%

UroGen Pharma

Market Cap: US$509.8m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

URGN

US$10.63

7D

-6.8%

1Y

-24.6%

Real Consulting

Market Cap: €93.6m

Provides IT solutions in Europe.

REALCONS

€4.39

7D

3.8%

1Y

4.5%

LEM Holding

Market Cap: CHF 811.1m

Provides solutions for measuring electrical parameters in China, Japan, South Korea, India, Southeast Asia, Europe, Middle East, Africa, NAFTA and Latin America.

LEHN

CHF 712.00

7D

-8.0%

1Y

-57.5%

StrongPoint

Market Cap: NOK 438.1m

Develops, sells, and implements integrated technology solutions for in-store and online shopping in Scandinavia and internationally.

STRO

NOK 9.80

7D

-2.5%

1Y

-27.7%

Checkpoint Therapeutics

Market Cap: US$197.3m

A clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

CKPT

US$4.04

7D

-0.5%

1Y

110.4%

ARS Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops treatments for severe allergic reactions.

SPRY

US$12.53

7D

-4.7%

1Y

35.0%

Duos Technologies Group

Market Cap: US$47.4m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

DUOT

US$5.22

7D

-15.1%

1Y

50.0%

Silence Therapeutics

Market Cap: US$133.2m

A biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

SLN

US$2.42

7D

-33.1%

1Y

-88.6%

NTG Clarity Networks

Market Cap: CA$73.4m

Provides telecommunications engineering, information technology, networking, and related software solutions worldwide.

NCI

CA$1.87

7D

-0.5%

1Y

367.5%

TruGolf Holdings

Market Cap: US$7.5m

Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.

TRUG

US$0.35

7D

-11.2%

1Y

-72.8%

SpringWorks Therapeutics

Market Cap: US$3.3b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

SWTX

US$41.88

7D

-11.3%

1Y

-9.5%

OS Therapies

Market Cap: US$32.7m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$1.33

7D

-16.4%

1Y

n/a

Soleno Therapeutics

Market Cap: US$3.3b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

SLNO

US$68.26

7D

36.4%

1Y

63.3%

Madrigal Pharmaceuticals

Market Cap: US$7.3b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$323.98

7D

-5.6%

1Y

32.5%

Capricor Therapeutics

Market Cap: US$432.8m

A clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs.

CAPR

US$9.48

7D

-29.7%

1Y

37.5%

Roadzen

Market Cap: US$87.5m

Operates as an insurance technology company.

RDZN

US$1.18

7D

10.3%

1Y

-80.5%

MeiraGTx Holdings

Market Cap: US$534.6m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

MGTX

US$6.16

7D

-20.9%

1Y

11.4%

RenovoRx

Market Cap: US$35.2m

A clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$0.96

7D

-9.4%

1Y

-22.6%

Facilities by ADF

Market Cap: UK£20.5m

Provides premium serviced production facilities, location, and equipment hire to the film and high-end television industry in the United Kingdom and Europe.

ADF

UK£0.19

7D

3.4%

1Y

-62.0%

f-code

Market Cap: JP¥20.4b

f-Code Inc. provides digital customer acquisition and development support services in Japan.

9211

JP¥1,660.00

7D

-5.7%

1Y

-30.8%

Chant Sincere

Market Cap: NT$5.2b

Engages in the design, manufacture, and sale of connectors and cable products in Taiwan.

6205

NT$65.00

7D

-3.6%

1Y

-16.6%

Page 4 of 33